AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
Summary
Pharmaceutical giant AstraZeneca reportedly attempted to acquire obesity medication developer Rhythm Pharmaceuticals with a ten billion dollar bid. Insiders indicate that the significant takeover proposal highlights growing interest in the lucrative weight-loss treatment market.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.